贝泰妮(300957) - 2021 Q3 - 季度财报

Revenue and Profitability - The company's revenue for Q3 2021 reached ¥700,987,805.50, an increase of 47.29% compared to the same period last year[3] - Net profit attributable to shareholders was ¥90,236,287.39, reflecting a growth of 64.29% year-over-year[3] - The net profit after deducting non-recurring gains and losses was ¥80,249,162.12, up 75.81% from the previous year[3] - Basic earnings per share for the period were ¥0.21, a rise of 39.62% compared to the same period last year[3] - The company's operating revenue for the first three quarters of 2021 was RMB 2,112.73 million, an increase of RMB 695.27 million or 49.05% compared to the same period last year[11] - The net profit for the first three quarters of 2021 was RMB 355.76 million, representing an increase of RMB 141.59 million or 66.11% year-over-year[11] - Total operating revenue for Q3 2021 reached ¥2,112,732,227.08, a significant increase from ¥1,417,461,029.96 in the same period last year, representing a growth of approximately 49%[25] - Operating profit for Q3 2021 was ¥421,042,422.70, compared to ¥254,279,075.42 in Q3 2020, indicating an increase of about 65.5%[25] - Net profit attributable to shareholders of the parent company was ¥355,251,880.40, up from ¥215,270,774.20 in the previous year, reflecting a growth of approximately 65%[26] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥4,965,157,252.13, representing a 209.96% increase compared to the end of the previous year[3] - The company's total equity attributable to shareholders increased by 254.25% to ¥4,247,533,129.15 compared to the end of the previous year[4] - The company reported a significant increase in cash and cash equivalents, with a year-end balance of ¥2,452,526,054.20, up 226.15% from the previous year[6] - The company's accounts payable at the end of the period was RMB 328.82 million, an increase of RMB 212.13 million or 181.81% compared to the end of the previous year, due to increased procurement[10] - Total liabilities reached CNY 704,796,270.92, up from CNY 400,051,900.60, reflecting a growth of about 76%[23] - The company's equity attributable to shareholders rose to CNY 4,247,533,129.15 from CNY 1,199,004,473.80, indicating an increase of approximately 254%[23] - The total liabilities rose from ¥400,051,900.60 to ¥481,515,811.99, representing an increase of approximately 20.3%[32] - The long-term liabilities increased significantly from ¥8,861,420.32 to ¥62,016,855.57, marking a rise of about 600%[32] Cash Flow - The company's cash flow from operating activities showed a significant increase of 499.88%, totaling ¥347,996,708.52 year-to-date[3] - Operating cash inflow for the first nine months of 2021 was CNY 2,400.83 million, an increase of CNY 848.28 million or 54.64% compared to the same period in 2020, driven by rapid growth in sales scale and revenue[14] - Operating cash outflow for the first nine months of 2021 was CNY 2,052.83 million, an increase of CNY 558.29 million or 37.36% year-on-year, mainly due to increased payments for production procurement and marketing expenses[15] - The company achieved cash inflow from operating activities totaling ¥2,400,829,204.09, compared to ¥1,552,550,925.88 in the previous year, indicating a growth of about 54.6%[28] - The net cash flow from financing activities was ¥2,656,297,808.11, a significant increase compared to the previous year's net outflow of ¥68,780,753.23[29] Research and Development - The company's R&D expenses for the first three quarters of 2021 were RMB 68.48 million, an increase of RMB 21.08 million or 44.48% compared to the same period last year, reflecting increased investment in R&D activities[11] - Research and development expenses for Q3 2021 amounted to ¥68,481,467.15, compared to ¥47,399,552.53 in Q3 2020, marking an increase of about 44.5%[25] Inventory and Production - The company has seen a substantial increase in inventory, which rose by 98.82% to ¥504,500,859.14 compared to the previous year[6] - The company's inventory at the end of the period was RMB 504.50 million, an increase of RMB 250.75 million or 98.82% compared to the end of the previous year, due to proactive production and procurement for promotional activities[8] - The company's construction in progress at the end of the period was RMB 118.82 million, an increase of RMB 78.07 million or 191.60%, due to ongoing investments in new factory projects[8] Government Subsidies and Financial Activities - The company received government subsidies amounting to ¥13,781,784.92 during the reporting period, primarily related to stock listing rewards[5] - The company's investment income for the first three quarters of 2021 was RMB 8.00 million, a substantial increase of RMB 6.88 million or 610.49% year-over-year, attributed to returns from financial products[11] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 25,969, with the largest shareholder, Kunming Nona Technology Co., Ltd., holding 46.08% of shares[17] - Kunming Nona Technology Co., Ltd. and Yunnan Haqi Enterprise Management Co., Ltd. are controlled by the same actual controller, Zhenyu Guo[18] - The company plans to lift restrictions on shares held by major shareholders on March 25, 2022, and March 25, 2024, for various shareholders[19] Future Outlook - The company plans to continue expanding its market presence and investing in new product development to drive future growth[22] - The increase in cash reserves positions the company well for potential acquisitions and strategic investments in the coming quarters[21] Financial Reporting and Standards - The company has not yet audited the third-quarter report, indicating that the figures are preliminary[34] - The company is implementing new leasing standards starting from 2021, which may affect future financial reporting[30]

Yunnan Botanee Bio-Technology -贝泰妮(300957) - 2021 Q3 - 季度财报 - Reportify